Sofosbuvir plus pegylated interferon and ribavirin in patients with genotype 1 hepatitis C virus in whom previous therapy with direct‐acting antivirals has failed-Reference-Cited by-同舟云学术

Sofosbuvir plus pegylated interferon and ribavirin in patients with genotype 1 hepatitis C virus in whom previous therapy with direct‐acting antivirals has failed

Published:2015-05-20 Issue:1 Volume:62 Page:129-134
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Pol Stanislas¹,Sulkowski Mark S.²,Hassanein Tarek³,Gane Edward J.⁴,Liu Lin⁵,Mo Hongmei⁵,Doehle Brian⁵,Kanwar Bittoo⁵,Brainard Diana⁵,Subramanian G. Mani⁵,Symonds William T.⁵,McHutchison John G.⁵,Nahass Ronald G.⁶,Bennett Michael⁷,Jacobson Ira M.⁸

Affiliation:

1. Université Paris Descartes, Hôpital Cochin, Inserm UMS20, Institut PasteurParis France

2. John Hopkins UniversityBaltimore MD

3. Southern California Liver CenterCoronado CA

4. Aukland City HospitalAuckland NZ

5. Gilead Sciences, Inc.Foster City CA

6. Infectious Disease CareHillsborough NJ

7. Medical Associates Research GroupSan Diego CA

8. Weill Cornell Medical CollegeNew York NY

Publisher

Wiley

Subject